ArticleFrontiers in immunology2022

Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.

Shu-Ming Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.